A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01)
Patent
CA 2616116
The present invention relates to a cell-targeting complex comprising a targeting moiety and a deliverable compound, wherein said targeting moiety and said deliverable compound are joined by means of a (transition) metal ion complex having at least a first reactive moiety for forming a coordination bond with a reactive site of said targeting moiety and having at least a second reactive moiety for forming a coordination bond with a reactive site of said deliverable compound, and wherein said deliverable compound is a therapeutic compound.
L'invention concerne un complexe de ciblage de cellules comprenant un fragment de ciblage et un composé administrable, ledit fragment de ciblage et ledit composé administrable étant liés par un complexe d'ions métalliques (de transition) ayant au moins un premier fragment réactif pour former une liaison de coordination avec un site réactif dudit fragment de ciblage et ayant au moins un second fragment réactif pour former une liaison de coordination avec un site réactif dudit composé administrable, ce composé administrable étant un composé thérapeutique.
Heetebrij Robert Jochem
Kok Robbert Jan
Molema Grietje
Poelstra Klaas
Talman Eduard Gerhard
Borden Ladner Gervais Llp
Kreatech Biotechnology B.v.
LandOfFree
Method of conjugating therapeutic compounds to cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of conjugating therapeutic compounds to cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of conjugating therapeutic compounds to cell... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1499486